<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>8685321</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">34938158</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">8685321</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.3389/fnins.2021.799916</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>TABLE 1</table-label><table-caption>Demographic and clinical characteristics of TAO group and HCs.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="T1"><label>TABLE 1</label><caption><p>Demographic and clinical characteristics of TAO group and HCs.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left" rowspan="1" colspan="1">Items</td><td valign="top" align="center" rowspan="1" colspan="1">TAO group (<italic toggle="yes">n</italic> = 28)</td><td valign="top" align="center" rowspan="1" colspan="1">HCs (<italic toggle="yes">n</italic> = 22)</td><td valign="top" align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Age (years)</td><td valign="top" align="center" rowspan="1" colspan="1">44.25 ± 12.71</td><td valign="top" align="center" rowspan="1" colspan="1">44.27 ± 12.75</td><td valign="top" align="center" rowspan="1" colspan="1">0.907<xref rid="t1fna" ref-type="table-fn"><sup>a</sup></xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Gender (female/male)</td><td valign="top" align="center" rowspan="1" colspan="1">15/13</td><td valign="top" align="center" rowspan="1" colspan="1">12/10</td><td valign="top" align="center" rowspan="1" colspan="1">0.945<xref rid="t1fnb" ref-type="table-fn"><sup>b</sup></xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Disease duration (months)</td><td valign="top" align="center" rowspan="1" colspan="1">18.39 ± 20.90</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CAS</td><td valign="top" align="center" rowspan="1" colspan="1">2.54 ± 1.26</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Visual acuity</td><td valign="top" align="center" rowspan="1" colspan="1">0.81 ± 0.25</td><td valign="top" align="center" rowspan="1" colspan="1">0.98 ± 0.18</td><td valign="top" align="center" rowspan="1" colspan="1">0.009<xref rid="t1fnc" ref-type="table-fn"><sup>c</sup></xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">QoL scores</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Visual functioning</td><td valign="top" align="center" rowspan="1" colspan="1">61.95 ± 26.77</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Appearance</td><td valign="top" align="center" rowspan="1" colspan="1">66.65 ± 19.70</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total score of HARS</td><td valign="top" align="center" rowspan="1" colspan="1">15.39 ± 8.51</td><td valign="top" align="center" rowspan="1" colspan="1">2.68 ± 2.61</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<xref rid="t1fna" ref-type="table-fn"><sup>a</sup></xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total score of HDRS</td><td valign="top" align="center" rowspan="1" colspan="1">15.25 ± 9.96</td><td valign="top" align="center" rowspan="1" colspan="1">2.23 ± 1.93</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<xref rid="t1fna" ref-type="table-fn"><sup>a</sup></xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total score of MoCA</td><td valign="top" align="center" rowspan="1" colspan="1">26.75 ± 2.66</td><td valign="top" align="center" rowspan="1" colspan="1">29.09 ± 1.02</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001<xref rid="t1fna" ref-type="table-fn"><sup>a</sup></xref></td></tr></tbody></table><table-wrap-foot><fn><p><italic toggle="yes">Data were presented as mean ± standard deviation unless otherwise indicated.</italic></p></fn><fn><p><italic toggle="yes">CAS, clinical activity score; QoL, quality of life; HARS, Hamilton Anxiety Rating Scale; HDRS, Hamilton Depression Rating Scale; MoCA, Montreal Cognitive Assessment; TAO, thyroid-associated ophthalmopathy; HCs, healthy controls; n, number of subjects.</italic></p></fn><fn id="t1fna"><p><italic toggle="yes"><sup>a</sup>P-value with Mann–Whitney test.</italic></p></fn><fn id="t1fnb"><p><italic toggle="yes"><sup>b</sup>P-value with Chi-square test.</italic></p></fn><fn id="t1fnc"><p><italic toggle="yes"><sup>c</sup>P-value with two-sample t-test.</italic></p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>TABLE 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic and clinical characteristics of TAO group and HCs.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left">Items</td><td valign="top" align="center">TAO group (n = 28)</td><td valign="top" align="center">HCs (n = 22)</td><td valign="top" align="center">P-value</td></tr></thead><tbody><tr><td valign="top" align="left">Age (years)</td><td valign="top" align="center">44.25 ± 12.71</td><td valign="top" align="center">44.27 ± 12.75</td><td valign="top" align="center">0.907???</td></tr><tr><td valign="top" align="left">Gender (female/male)</td><td valign="top" align="center">15/13</td><td valign="top" align="center">12/10</td><td valign="top" align="center">0.945???</td></tr><tr><td valign="top" align="left">Disease duration (months)</td><td valign="top" align="center">18.39 ± 20.90</td><td valign="top" align="center">–</td><td/></tr><tr><td valign="top" align="left">CAS</td><td valign="top" align="center">2.54 ± 1.26</td><td valign="top" align="center">–</td><td/></tr><tr><td valign="top" align="left">Visual acuity</td><td valign="top" align="center">0.81 ± 0.25</td><td valign="top" align="center">0.98 ± 0.18</td><td valign="top" align="center">0.009???</td></tr><tr><td valign="top" align="left">QoL scores</td><td/><td/><td/></tr><tr><td valign="top" align="left">Visual functioning</td><td valign="top" align="center">61.95 ± 26.77</td><td valign="top" align="center">–</td><td/></tr><tr><td valign="top" align="left">Appearance</td><td valign="top" align="center">66.65 ± 19.70</td><td valign="top" align="center">–</td><td/></tr><tr><td valign="top" align="left">Total score of HARS</td><td valign="top" align="center">15.39 ± 8.51</td><td valign="top" align="center">2.68 ± 2.61</td><td valign="top" align="center">&lt;0.001???</td></tr><tr><td valign="top" align="left">Total score of HDRS</td><td valign="top" align="center">15.25 ± 9.96</td><td valign="top" align="center">2.23 ± 1.93</td><td valign="top" align="center">&lt;0.001???</td></tr><tr><td valign="top" align="left">Total score of MoCA</td><td valign="top" align="center">26.75 ± 2.66</td><td valign="top" align="center">29.09 ± 1.02</td><td valign="top" align="center">&lt;0.001???</td></tr></tbody></table></div>Data were presented as mean ± standard deviation unless otherwise indicated.CAS, clinical activity score; QoL, quality of life; HARS, Hamilton Anxiety Rating Scale; HDRS, Hamilton Depression Rating Scale; MoCA, Montreal Cognitive Assessment; TAO, thyroid-associated ophthalmopathy; HCs, healthy controls; n, number of subjects.aP-value with Mann–Whitney test.bP-value with Chi-square test.cP-value with two-sample t-test.</transformed-table></extracted-table><extracted-table><table-id>T2</table-id><table-label>TABLE 2</table-label><table-caption>Brain areas with significantly different static and dynamic VMHC values between groups (P &lt; 0.05, cluster-level FWE corrected).</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="T2"><label>TABLE 2</label><caption><p>Brain areas with significantly different static and dynamic VMHC values between groups (<italic toggle="yes">P</italic> &lt; 0.05, cluster-level FWE corrected).</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left" rowspan="1" colspan="1">Brain regions/conditions</td><td valign="top" align="center" rowspan="1" colspan="1">BA</td><td valign="top" align="center" colspan="3" rowspan="1">MNI coordinates<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Cluster size (number of voxels)</td><td valign="top" align="center" rowspan="1" colspan="1"><italic toggle="yes">t</italic>-Value</td></tr><tr><td valign="top" align="justify" rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">X</td><td valign="top" align="center" rowspan="1" colspan="1">Y</td><td valign="top" align="center" rowspan="1" colspan="1">Z</td><td valign="top" align="justify" rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold><italic toggle="yes">Static VMHC</italic></bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="justify" rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>TAO group &lt; HCs</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="justify" rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">R/L LG/CAL</td><td valign="top" align="center" rowspan="1" colspan="1">18/19</td><td valign="top" align="center" rowspan="1" colspan="1">27/−27</td><td valign="top" align="center" rowspan="1" colspan="1">−54</td><td valign="top" align="center" rowspan="1" colspan="1">−3</td><td valign="top" align="center" rowspan="1" colspan="1">120</td><td valign="top" align="center" rowspan="1" colspan="1">−4.763</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">R/L MOG</td><td valign="top" align="center" rowspan="1" colspan="1">19/37/39</td><td valign="top" align="center" rowspan="1" colspan="1">36/−36</td><td valign="top" align="center" rowspan="1" colspan="1">−78</td><td valign="top" align="center" rowspan="1" colspan="1">18</td><td valign="top" align="center" rowspan="1" colspan="1">52</td><td valign="top" align="center" rowspan="1" colspan="1">−4.579</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">R/L PoCG</td><td valign="top" align="center" rowspan="1" colspan="1">3/4/43</td><td valign="top" align="center" rowspan="1" colspan="1">48/−48</td><td valign="top" align="center" rowspan="1" colspan="1">−15</td><td valign="top" align="center" rowspan="1" colspan="1">39</td><td valign="top" align="center" rowspan="1" colspan="1">71</td><td valign="top" align="center" rowspan="1" colspan="1">−4.574</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">R/L SPL</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">27/−27</td><td valign="top" align="center" rowspan="1" colspan="1">−57</td><td valign="top" align="center" rowspan="1" colspan="1">57</td><td valign="top" align="center" rowspan="1" colspan="1">48</td><td valign="top" align="center" rowspan="1" colspan="1">−5.621</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">R/L IPL</td><td valign="top" align="center" rowspan="1" colspan="1">40</td><td valign="top" align="center" rowspan="1" colspan="1">39/−39</td><td valign="top" align="center" rowspan="1" colspan="1">−48</td><td valign="top" align="center" rowspan="1" colspan="1">36</td><td valign="top" align="center" rowspan="1" colspan="1">41</td><td valign="top" align="center" rowspan="1" colspan="1">−4.897</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">R/L PCu</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">9/−9</td><td valign="top" align="center" rowspan="1" colspan="1">−69</td><td valign="top" align="center" rowspan="1" colspan="1">54</td><td valign="top" align="center" rowspan="1" colspan="1">55</td><td valign="top" align="center" rowspan="1" colspan="1">−4.777</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold><italic toggle="yes">Dynamic VMHC</italic></bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="justify" rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>TAO group &gt; HCs</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="justify" rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">R/L OFC</td><td valign="top" align="center" rowspan="1" colspan="1">11/47</td><td valign="top" align="center" rowspan="1" colspan="1">30/−30</td><td valign="top" align="center" rowspan="1" colspan="1">57</td><td valign="top" align="center" rowspan="1" colspan="1">−6</td><td valign="top" align="center" rowspan="1" colspan="1">20</td><td valign="top" align="center" rowspan="1" colspan="1">5.551</td></tr></tbody></table><table-wrap-foot><fn><p><italic toggle="yes">VMHC, voxel-mirrored homotopic connectivity; FWE, family-wise error; BA, Brodmann’s areas; MNI, Montreal Neurologic Institute; TAO, thyroid-associated ophthalmopathy; HCs, healthy controls; R, right; L, left; LG, lingual gyrus; CAL, calcarine; MOG, middle occipital gyrus; PoCG, postcentral gyrus; SPL, superior parietal lobule; IPL, inferior parietal lobule; PCu, precuneus; OFC, orbitofrontal cortex.</italic></p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>TABLE 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Brain areas with significantly different static and dynamic VMHC values between groups (P &lt; 0.05, cluster-level FWE corrected).</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left">Brain regions/conditions</td><td valign="top" align="center">BA</td><td valign="top" align="center" colspan="3">MNI coordinates</td><td valign="top" align="left">Cluster size (number of voxels)</td><td valign="top" align="center">t-Value</td></tr><tr><td valign="top" align="justify"/><td/><td valign="top" align="center">X</td><td valign="top" align="center">Y</td><td valign="top" align="center">Z</td><td valign="top" align="justify"/><td/></tr></thead><tbody><tr><td valign="top" align="left">Static VMHC</td><td/><td/><td/><td/><td valign="top" align="justify"/><td/></tr><tr><td valign="top" align="left">TAO group &lt; HCs</td><td/><td/><td/><td/><td valign="top" align="justify"/><td/></tr><tr><td valign="top" align="left">R/L LG/CAL</td><td valign="top" align="center">18/19</td><td valign="top" align="center">27/−27</td><td valign="top" align="center">−54</td><td valign="top" align="center">−3</td><td valign="top" align="center">120</td><td valign="top" align="center">−4.763</td></tr><tr><td valign="top" align="left">R/L MOG</td><td valign="top" align="center">19/37/39</td><td valign="top" align="center">36/−36</td><td valign="top" align="center">−78</td><td valign="top" align="center">18</td><td valign="top" align="center">52</td><td valign="top" align="center">−4.579</td></tr><tr><td valign="top" align="left">R/L PoCG</td><td valign="top" align="center">3/4/43</td><td valign="top" align="center">48/−48</td><td valign="top" align="center">−15</td><td valign="top" align="center">39</td><td valign="top" align="center">71</td><td valign="top" align="center">−4.574</td></tr><tr><td valign="top" align="left">R/L SPL</td><td valign="top" align="center">7</td><td valign="top" align="center">27/−27</td><td valign="top" align="center">−57</td><td valign="top" align="center">57</td><td valign="top" align="center">48</td><td valign="top" align="center">−5.621</td></tr><tr><td valign="top" align="left">R/L IPL</td><td valign="top" align="center">40</td><td valign="top" align="center">39/−39</td><td valign="top" align="center">−48</td><td valign="top" align="center">36</td><td valign="top" align="center">41</td><td valign="top" align="center">−4.897</td></tr><tr><td valign="top" align="left">R/L PCu</td><td valign="top" align="center">7</td><td valign="top" align="center">9/−9</td><td valign="top" align="center">−69</td><td valign="top" align="center">54</td><td valign="top" align="center">55</td><td valign="top" align="center">−4.777</td></tr><tr><td valign="top" align="left">Dynamic VMHC</td><td/><td/><td/><td/><td valign="top" align="justify"/><td/></tr><tr><td valign="top" align="left">TAO group &gt; HCs</td><td/><td/><td/><td/><td valign="top" align="justify"/><td/></tr><tr><td valign="top" align="left">R/L OFC</td><td valign="top" align="center">11/47</td><td valign="top" align="center">30/−30</td><td valign="top" align="center">57</td><td valign="top" align="center">−6</td><td valign="top" align="center">20</td><td valign="top" align="center">5.551</td></tr></tbody></table></div>VMHC, voxel-mirrored homotopic connectivity; FWE, family-wise error; BA, Brodmann’s areas; MNI, Montreal Neurologic Institute; TAO, thyroid-associated ophthalmopathy; HCs, healthy controls; R, right; L, left; LG, lingual gyrus; CAL, calcarine; MOG, middle occipital gyrus; PoCG, postcentral gyrus; SPL, superior parietal lobule; IPL, inferior parietal lobule; PCu, precuneus; OFC, orbitofrontal cortex.</transformed-table></extracted-table></extracted-tables-set>